Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 1 - 50 out of 10,978

Document Document Title
WO/2021/064166A1
The presented invention relates to crystalline Form A and Form B of Bempedoic acid, a process for preparation thereof and a composition comprising the Form A or Form B.  
WO/2021/063166A1
A ligand for a quantum dot, a coordinated quantum dot, a quantum dot layer and a patterning method therefor. The cleavage ligand comprises a first coordination unit A, a cleavage unit B, and an adhesion regulating unit C. The cleavage li...  
WO/2021/056850A1
Provided are an eutectic crystal formed by apixaban and a carboxylic acid, and a preparation method therefor. The eutectic crystal comprises an apixaban/malonic acid eutectic crystal, an apixaban/D‐malate eutectic crystal, an apixaban/...  
WO/2021/042411A1
Disclosed are an AKR1C3 inhibitor or a pharmaceutically acceptable salt of same, a preparation method for same, and uses thereof. A structural optimization is performed with a nonsteroidal anti-inflammatory medicament, flurbiprofen, serv...  
WO/2021/041898A1
Disclosed herein are embodiments of a pyrazole compound according to formula (I). Compositions comprising the compound, and a method for making the composition also are disclosed. The composition may comprise a carrier, such as a polymer...  
WO/2021/040267A1
The present invention relates to a method of extracting caffeic acid and rosmarinic acid from rosemary, and more specifically, to a method of extracting caffeic acid and rosmarinic acid from rosemary, the method comprising the steps of: ...  
WO/2021/030437A1
Laundry detergent builder additives are described. Laundry detergent builder additives are water softeners that work to maintain detergent stability and improve the cleaning efficiency of the detergent formulation. These detergent additi...  
WO/2021/016720A1
The present technology generally relates to a triploid Cannabis plant, triploid Cannabis seeds and to methods for generating such triploid Cannabis plant. The methods comprise crossing a tetraploid Cannabis plant with a diploid Cannabis ...  
WO/2021/012722A1
The present invention belongs to the technical field of chemical pharmaceutical engineering. Provided are a sodium 3-hydroxybutyrate product and a preparation method therefor. The sodium 3-hydroxybutyrate product has a degree of crystall...  
WO/2021/011810A1
A process for a reactive extraction and subsequent purification of organic molecules from biomass comprises extracting one or more products from the biomass using an extraction solvent to solvate the products, contacting the biomass with...  
WO/2021/009374A1
The present invention relates to ionic liquid-type compounds having formula (I). The invention also relates to the use of such compounds for the dissolution and/or extraction of at least one compound of biological origin, such as a biopo...  
WO/2021/001457A1
The present invention relates to crystalline salt forms of (R)-2-amino-3-phenylpropylcarbamate and a process for their preparation. The invention also relates to a pharmaceutical composition comprising one or more of the crystalline salt...  
WO/2020/258131A1
Provided is a method for preparing glycolic acid which comprises oxidizing glycolaldehyde with molecular oxygen in the presence of a solvent and a supported catalyst. Said supported catalyst comprises (i) a noble metal selected from the ...  
WO/2020/262406A1
[Problem] To provide a method for heating anhydrous sodium silicate (cullet), a chelating agent, and water to obtain a sodium silicate aqueous solution and a method for producing a high-purity silica sol using the sodium silicate aqueous...  
WO/2020/254559A1
The present disclosure relates to compounds suitable for treating, ameliorating and/or preventing neuromuscular disorders, including the reversal of drug-induced neuromuscular blockade. The compounds as defined herein can inhibit the ClC...  
WO/2020/257571A1
The invention provides methods of preparing 8-hy droxy-2,2, 14,14- tetramethylpentadecanedioic acid and methods of making a pharmaceutical material comprising a purified amount of 8-hy droxy-2,2, 14, 14-tetramethylpentadecanedioic acid. ...  
WO/2020/254553A1
The present disclosure relates to compounds suitable for treating, ameliorating and/or preventing neuromuscular disorders, including the reversal of drug-induced neuromuscular blockade. The compounds as defined herein preferably inhibit ...  
WO/2020/253076A1
Discloses the use of a hydroxycarboxylic acid compound for controlling plant diseases by fungi and oomycetes, wherein the hydroxycarboxylic acid compound is selected from compounds of formulas (I), (II), (III) and (IV), as well as isomer...  
WO/2020/165658A3
A method for preventing unwanted side effects associated with the administration stimulant laxative such as bisacodyl or sodium picosulphate by orally administering sodium chloride to the patient is disclosed. Said side effects include h...  
WO/2020/243907A1
The present invention relates to a method of synthesizing at least one organic acid comprising oxidizing glycolaldehyde with nitric acid in the presence of a solvent. Advantageously, it is an industrially applicable process, which prepar...  
WO/2020/239568A1
There is disclosed a salt of Formula III, a method for manufacturing thereof as well as uses thereof. ( Formula III ), wherein X is H or OH, Y is H or a cation selected from the group consisting of Li, Na and K, is a single bond or a dou...  
WO/2020/232536A1
Described herein are processes and enzymes for the enzymatic production of glucaric acid from glucuronic acid, and more specifically the enzymatic production of substituted glucaric acid from substituted glucuronic acid. Advantageously, ...  
WO/2020/232542A1
The present disclosure relates to carbon dots, uses thereof and methods of manufacture thereof. For example, such carbon dots can be used in the production of biofuels such as biodiesel. For example, these carbon dots can be used as cata...  
WO/2020/234379A1
Disclosed is a process for the preparation of certain intermediates, e.g. process for preparing a compound of formula (I) or a pharmaceutically acceptable salt thereof, in an enantioenriched form, which intermediate and processes are use...  
WO/2020/233588A1
Disclosed are a new crystal form of a treprostinil sodium salt (the structural formula thereof is shown as formula I) and a preparation method therefor. Specifically, disclosed are a five and half hydrates of the treprostinil sodium salt...  
WO/2020/231146A1
The present invention relates to a novel salt of pelubiprofen, and a preparation method therefor and a pharmaceutical composition comprising same. Particularly, the present invention relates to a novel tromethamine salt of pelubiprofen, ...  
WO/2020/228713A1
Disclosed is a method for extracting useful substances from shrimp shells. The method comprises: crushing the shrimp shells, mixing the crushed shrimp shells and water, then heating same to 28℃-35℃, adjusting the pH to 6.8-7.5, prefe...  
WO/2020/226114A1
The present invention addresses the problem of providing a novel method for producing 2, 2'-bis(carboxymethoxy)-1, 1'-binaphthyl that is suitable as a resin starting material having excellent optical characteristics. The present inventio...  
WO/2020/209796A3
A method of identifying a mycobacterium using surface enhanced Raman spectroscopy (SERS), disclosed herein, comprises disposing a sample suspected to comprise a mycobacterium on a SERS-active substrate, detecting surface enhanced Raman s...  
WO/2020/214841A1
Salts of hexylamine, for example, hexylamine succinate and tri-hexylamine citrate and their method of production are described. The disclosure also relates to compositions comprises hexyalmine and the use of hexylamine for for reducing a...  
WO/2020/214835A1
Provided are methods for producing levulinic acid from hemp hurds. In some embodiments, the methods include dissolving hemp hurds in an ionic liquid medium to produce a cellulose-rich product; hydrolyzing cellulose present in the cellulo...  
WO/2020/208594A1
The present invention provides various solid state forms of elafibranor. In an aspect of present invention provides a stable amorphous form of elafibranor and its processes. The present invention also provides a stable admixture form of ...  
WO/2020/200952A1
The present invention pertains to a process for preparing 3-hydroxy-3-methylbutyrate (HMB) or a salt thereof, the method comprising (a) reacting isobutylene oxide with cyanide in order to obtain 3- hydroxy-3-methylbutyronitrile, and (b) ...  
WO/2020/206448A1
Provided are methods of using compounds, pharmaceutical compositions, cosmetic and dermatological compositions or nutritional supplement compositions, comprising omega-3 very-long-chain polyunsaturated fatty acids (n-3 VLC-PUFAs) and/or ...  
WO/2020/194152A1
Aspect of the present application provides cost effective and commercially viable process for preparation of Bempedoic acid. The process involves the reduction of compound formula I to obtain compound formula II which is hydrolyzed to ge...  
WO/2020/193681A1
The present invention relates to derivatives of 10-methylene lipids, their preparation and their use.  
WO/2020/184054A1
The present invention provides a (meth)acrylic-acid-metal-salt-containing composition that has exceptional solubility/dispersibility (preferably solubility) in low-polarity media and that resists bleed out of the metal salt. The present ...  
WO/2020/173961A1
The invention relates to a method for degradation of plastic materials into terephthalic acid (TPA)and/or ethylene glycol and/or other monomers that form the plastic materials.  
WO/2020/174096A1
Compounds of the formula (I), wherein the substituents are as defined in claim 1. Furthermore, the present invention relates to agrochemical compositions which comprise compounds of formula (I), to preparation of these compositions, and ...  
WO/2020/171039A1
This invention addresses the problem of providing a novel fluorene compound, which has a 2,3-benzofluorene skeleton, is highly versatile as a "dicarboxylic acid component" of a resin starting material, has a high refractive index, and is...  
WO/2020/141419A3
The present invention relates to novel pharmaceutically acceptable salts of Bempedoic acid, novel intermediates of Bempedoic acid, novel crystalline form of Bempedoic acid and novel processes for the preparation of Bempedoic acid or its ...  
WO/2020/158752A1
[Problem] To provide an adsorbent recycling method for regenerating a used adsorbent and allowing purification capability to be exhibited stably in order to maintain constant the composition of a synthetic gas that has been purified usin...  
WO/2020/127243A3
The present invention relates to ethoxylate surfactant compounds of general formula (I) A-X-0-[CH2-CH2-0]n-R1, wherein A is a linear C7-C33-alkyl or -alkenyl residue, wherein one of the hydrogen atoms is substituted by residue -O-[CH2-CH...  
WO/2020/150568A1
Methods for syntheses of organic acids from a-keto acids, including methods for syntheses of isotopically encriched organic acids from a-keto acids are disclosed. The isotopically enriched organic acids are useful, for example, in metabo...  
WO/2020/141419A2
The present invention relates to novel pharmaceutically acceptable salts of Bempedoic acid, novel intermediates of Bempedoic acid, novel crystalline form of Bempedoic acid and novel processes for the preparation of Bempedoic acid or its ...  
WO/2020/140309A1
The present invention provides a method for preparing a 3-hydroxybutyrate amino acid salt compound, comprising: (1) adding ethyl 3-hydroxybutyrate or methyl 3-hydroxybutyrate into a reaction vessel, taking water as a solvent, adding a ba...  
WO/2020/112941A3
The present disclosure relates to solid state forms of Lumateperone besylate and Lumateperone tosylate : R-(-)-mandelic acid, to various intermediates, to processes for their preparation and the preparation of Lumateperone or salt thereo...  
WO/2020/138902A1
The present invention relates to a catalyst compound in which a transition metal is coordinated to a ligand containing two or three chain-like imidazolium or triazolium functional groups, and a method for preparing a formate compound and...  
WO/2020/127243A2
The present invention relates to ethoxylate surfactant compounds of general formula (I) A-X-0-[CH2-CH2-0]n-R1, wherein A is a linear C7-C33-alkyl or -alkenyl residue, wherein one of the hydrogen atoms is substituted by residue -O-[CH2-CH...  
WO/2020/126088A1
The present invention refers to a co-crystal of Ketoprofen Lysine named Form 1, a pharmaceutical composition comprising said co-crystal, a process for its production and to its use in the treatment of pain and inflammatory diseases.  

Matches 1 - 50 out of 10,978